TR200002790T2 - 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip - Google Patents

5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip

Info

Publication number: TR200002790T2
Authority: TR; Turkey
Prior art keywords: thiazolidin; dione; pyridyl; ethoxy; benzyl
Prior art date: 1997-06-05

Application number

TR2000/02790T

Other languages

English (en)

Turkish (tr)

Inventor

Patel Jai

Ross Hamish

Price Robin

Roger Granett Jeffrey

Nigel Wray Paul

Original Assignee

Smithkline Beecham P.L.C.

Smithkline Beecham Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2001-11-21

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham P.L.C., Smithkline Beecham Corporation filed Critical Smithkline Beecham P.L.C.

2001-11-21 Publication of TR200002790T2 publication Critical patent/TR200002790T2/xx

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Obesity (AREA)
Hematology (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

TR2000/02790T 1997-06-05 1998-06-02 5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip TR200002790T2 (tr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
TR200002790T2 true TR200002790T2 (tr)	2001-11-21

Family

ID=26311662

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
TR2000/02790T TR200002790T2 (tr)	1997-06-05	1998-06-02	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
TR1999/02963T TR199902963T2 (xx)	1997-06-05	1998-06-02	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
TR1999/02963T TR199902963T2 (xx)	1997-06-05	1998-06-02	5-$4-$2-(N-Metil-N-2-Piridil)Amino) Etoksi]Benzil]Tiazolidin-2,4-Dion i�eren terkip

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (xx)
JP (1)	JP2001521553A (xx)
KR (1)	KR20010013410A (xx)
CN (3)	CN1526391A (xx)
AP (1)	AP1214A (xx)
AR (2)	AR015120A1 (xx)
AU (1)	AU8215098A (xx)
BG (1)	BG104048A (xx)
BR (1)	BR9810405A (xx)
CA (2)	CA2333352A1 (xx)
CO (1)	CO4940400A1 (xx)
DZ (1)	DZ2510A1 (xx)
EA (1)	EA002384B1 (xx)
GB (1)	GB9711683D0 (xx)
HU (1)	HUP0004070A3 (xx)
ID (1)	ID24264A (xx)
IL (1)	IL133074A0 (xx)
MX (1)	MXPA99011322A (xx)
NO (2)	NO995938L (xx)
NZ (2)	NZ523725A (xx)
OA (1)	OA11306A (xx)
PE (1)	PE78899A1 (xx)
PL (1)	PL337201A1 (xx)
SK (1)	SK164899A3 (xx)
TR (2)	TR200002790T2 (xx)
TW (1)	TW570797B (xx)
UY (1)	UY25032A1 (xx)
WO (1)	WO1998055122A1 (xx)
ZA (2)	ZA9811572B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL351684A1 (en)	1999-04-23	2003-06-02	Smithkline Beecham Plc	Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
BR0009934A (pt)	1999-04-23	2002-06-04	Smithkline Beecham Plc	Produto farmacêutico
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
AU2002350965A1 (en) *	2001-12-13	2003-06-23	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
EP1854794A1 (en) *	2006-05-09	2007-11-14	Teva Pharmaceutical Industries Ltd.	2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE186724T1 (de) *	1987-09-04	1999-12-15	Beecham Group Plc	Substituierte thiazolidindionderivate
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
SG47100A1 (en) *	1994-02-10	1998-03-20	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
WO1997005875A2 (en) *	1995-08-10	1997-02-20	Warner-Lambert Company	A method of reducing the amount of exogenous insulin administered to a patient having noninsulin-dependent diabetes mellitus
AU7604596A (en) *	1995-11-17	1997-06-11	Warner-Lambert Company	A method of treating myotonic dystrophy
IL120443A (en) *	1996-03-18	2000-07-16	Sankyo Co	Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
WO1998002159A1 (en) *	1996-07-12	1998-01-22	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 IL IL13307498A patent/IL133074A0/xx unknown
- 1998-06-02 JP JP50158799A patent/JP2001521553A/ja not_active Ceased
- 1998-06-02 PL PL98337201A patent/PL337201A1/xx unknown
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/zh active Pending
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/es unknown
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/hu unknown
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/xx unknown
- 1998-06-02 SK SK1648-99A patent/SK164899A3/sk unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/zh not_active Expired - Lifetime
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Application Discontinuation
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/pt not_active IP Right Cessation
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 ID IDW991520A patent/ID24264A/id unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/ko not_active Application Discontinuation
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/xx unknown
- 1998-06-02 EA EA199901116A patent/EA002384B1/ru not_active IP Right Cessation
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/xx active
- 1998-06-04 CO CO98031614A patent/CO4940400A1/es unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/xx unknown
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/xx unknown
- 1998-06-04 AR ARP980102650A patent/AR015120A1/es not_active Application Discontinuation
- 1998-06-04 UY UY25032A patent/UY25032A1/es not_active IP Right Cessation
- 1998-06-04 AR ARP980102649A patent/AR008198A1/es not_active Application Discontinuation
- 1998-06-05 PE PE1998000466A patent/PE78899A1/es not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/zh not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/no not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/bg unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/xx unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/zh active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
BG104048A (bg)	2000-07-31
NO995938L (no)	2000-02-02
NO995938D0 (no)	1999-12-03
NZ523725A (en)	2004-09-24
OA11306A (en)	2003-10-22
SK164899A3 (en)	2000-11-07
CN1430959A (zh)	2003-07-23
HUP0004070A3 (en)	2002-03-28
CA2292629A1 (en)	1998-12-10
EA199901116A1 (ru)	2000-06-26
EA002384B1 (ru)	2002-04-25
WO1998055122A1 (en)	1998-12-10
CN1259050A (zh)	2000-07-05
NZ513922A (en)	2001-09-28
ID24264A (id)	2000-07-13
BR9810405A (pt)	2000-08-29
CA2333352A1 (en)	1998-12-10
HUP0004070A2 (hu)	2002-02-28
AU8215098A (en)	1998-12-21
PL337201A1 (en)	2000-08-14
CN1526391A (zh)	2004-09-08
DZ2510A1 (fr)	2003-01-25
AR015120A1 (es)	2001-04-18
IL133074A0 (en)	2001-03-19
UY25032A1 (es)	1998-11-26
TR199902963T2 (xx)	2000-02-21
AP1214A (en)	2003-10-08
KR20010013410A (ko)	2001-02-26
GB9711683D0 (en)	1997-08-06
ZA984826B (en)	1999-08-03
AP9901696A0 (en)	1999-12-31
PE78899A1 (es)	1999-10-22
JP2001521553A (ja)	2001-11-06
EP0998284A1 (en)	2000-05-10
NO20040738L (no)	2000-02-02
ZA9811572B (en)	1999-07-22
MXPA99011322A (es)	2004-12-02
CA2292629C (en)	2004-01-06
TW570797B (en)	2004-01-11
CO4940400A1 (es)	2000-07-24
CN1112926C (zh)	2003-07-02
AR008198A1 (es)	1999-12-29

Publication	Publication Date	Title
EA200601145A1 (ru)	2009-04-28	Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов
RS51343B (sr)	2011-02-28	Nova kompozicija i njena upotreba
TR200002790T2 (tr)	2001-11-21	5-(4-(2-(N-metil-N-2-piridil) amino)etoksi) benzil)tiazolidin-2,4-dion içeren terkip
NZ509239A (en)	2002-10-25	2-(4-(N-salicyloyl)aminophenyl)propionic acid useful as a carrier in compositions for delivering active agents
AP1545A (en)	2006-01-12	Hydrochloride salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
TR199800697T2 (xx)	1998-07-21	Farmas�tik olarak aktif kinazolin bile�imleri.
TR200103353T2 (tr)	2002-04-22	Bir füzyonlu heterosiklik bileşimin hidroklorid tuzu.
TR200001793T2 (tr)	2000-10-23	Yapısında değişiklik yapılmış tiyazolidinediyon türevi, bunun hazırlanması için işlem ve eczacılık alanında kullanımı
MY135973A (en)	2008-07-31	Modified release compositions comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, optionally in the form of pharmaceutically acceptable derivative
TR199802626A2 (xx)	1999-10-21	Yeni farmas�tikler.
RS49793B (sr)	2008-06-05	Postupak za dobijanje derivata tiazolidindiona
CO4940454A1 (es)	2000-07-24	Nuevo metodo de tratamiento
TR200103040T2 (tr)	2002-04-22	Yeni farmasötik maddeler
TR200103041T2 (tr)	2002-03-21	Yeni farmastik maddeler.
NZ515555A (en)	2002-09-27	Treatment of diabetes with thiazolidinedione and sulphonylurea
AP1715A (en)	2007-02-28	The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
CZ20011832A3 (cs)	2001-10-17	Nový farmaceutický přípravek a způsob jeho přípravy
GB0021784D0 (en)	2000-10-18	Novel pharmaceutical
DE60212434D1 (de)	2006-07-27	Rosiglitazon-edisylate und ihre verwendung als antidiabetika
RS50130B (sr)	2009-03-25	Farmaceutska kompozicija 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona
CY1107421T1 (el)	2012-12-19	Τρυγικα αλατα παραγωγου θειαζολιδινοδιονης
AP1738A (en)	2007-05-07	Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
AP2002002684A0 (en)	2002-12-31	5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
ECSP003434A (es)	2000-07-21	Nuevos compuestos
HUP0203476A2 (en)	2003-05-28	Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate, use thereof and pharmaceutical composition containing the same